Latest Sales Growth News

Bod Science Limited has reported a notable profit turnaround for FY2025, driven by medicinal cannabis sales growth, while navigating a complex Deed of Company Arrangement and a proposed backdoor listing with Biortica Agrimed Limited.

Premier Investments reported a 31.1% rise in net profit after tax for FY25, driven by strong sales growth at Peter Alexander and a strategic shift following the sale of its Apparel Brands to Myer.

Zimi Limited has completed its manufacturing transition, fulfilling over $1 million in backorders and restoring product availability in the Australian smart home market.

KMD Brands reported a modest 1% sales increase in FY25 but faced a sharp 65% drop in underlying EBITDA, prompting a bold 'Next Level' turnaround strategy targeting margin expansion and debt reduction in FY26.

KMD Brands reported a slight revenue increase to NZD 989 million for FY25 but faced significant underlying losses, prompting a strategic reset. The company also reinforced its commitment to tackling modern slavery risks across its global supply chain.

Myer Group posted modest sales growth in FY25, buoyed by the Apparel Brands acquisition, but faced profitability challenges from operational disruptions and macroeconomic pressures. The Group is advancing its omni-channel strategy and cost management initiatives while addressing National Distribution Centre issues.

MyEco Group has appointed Marie de Perthuis as its new CEO, aiming to leverage her extensive FMCG and retail experience to drive sales growth and build on recent operational restructuring.

Advanced Braking Technology has appointed CEO Andrew Booth to the Board as Managing Director, signaling confidence in his leadership amid ongoing growth.

dorsaVi has inked a five-year sales agreement with Select Medical, opening access to over 1,900 US outpatient physical therapy centers for its FDA-approved motion analysis products. This follows a successful 18-month pilot validating clinical benefits in athlete rehabilitation.

Briscoe Group Limited reported a near-flat half-year sales performance with a modest decline in net profit, while advancing key strategic investments including a new distribution centre. The company declared a 10-cent interim dividend amid cautious economic outlook.

The Calmer Co. reports a significant operational turnaround in H2 FY25, with sales momentum building through July and August, driven by cost reductions and new product launches in the US market.

Brambles Limited has clarified that its full-year 2025 earnings aligned closely with prior guidance and market expectations, with no material surprises. The company’s robust FY26 outlook, including increased dividends and a significant share buy-back, underpinned positive investor sentiment.